No Data
No Data
Needham Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $6
Express News | Needham Reiterates Buy on Taysha Gene Therapies, Maintains $6 Price Target
Taysha Gene Therapies: Promising Developments and Strategic Investment Opportunity
Express News | Taysha Gene Therapies Files for Mixed Shelf Offering of up to $300 Mln - SEC Filing
Express News | Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)